Providence Medical Technology has obtained CE mark for its DTRAX spinal system, DTRAX cervical cage, and DTRAX bone screw. This regulatory approval expands the company’s international product offering to include its entire DTRAX portfolio.
“We are extremely pleased by the continuing regulatory recognition for our innovative products in the cervical spine market,” said Margaret Wong, director of regulatory affairs at Providence. “This CE mark also gives us a clear regulatory path for new implants and instruments within the DTRAX family in the European Union.”
“Providence launched the DTRAX expandable cage system in 2011,” said Jeff Smith, chief executive officer of Providence. “Since then our surgeon customers have treated thousands of patients with cervical degenerative disc disease. We are excited that our international customers now have access to this expanded DTRAX product offering.”
